Note: Ingredients listed on restricted chemical lists
EC/CAS
202-318-7/94-26-8
Name of the chemical
Butyl 4-hydroxybenzoate
Concentration
<0.1
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
0.5%< >=5% <5% 0.5%<
EC/CAS
231-791-2/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
<25% 017-002- >=25% <25% >=10%
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
10%<=C<25%
EC/CAS
234-394-2/11138-66-2
Name of the chemical
xanthan gum
Concentration
<1
EC/CAS
231-545-4/7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
<1
EC/CAS
259-952-2/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
0.1-0.5
EC/CAS
202-785-7
Name of the chemical
4-Hydroxybenzoic acid and its Methyl- and Ethyl-esters, and their salts
Concentration
*
General Information
Version
5.01
Tarikh Semakan:
2026-02-16
A. Nama produk
Abrocitinib Oral Suspension
A. Nama produk
Abrocitinib Oral Suspension
Jenama
Tidak berkenaan
1.2 Nama Kimia:
EU - REACH (1907/2006) - Perkara EU - REACH (1907/2006) - Senarai 59(1) - Calon Senarai Bahan dengan Penilaian Bahan Gangguan Endokrin Kebimbangan Sangat Tinggi (SVHC) bagi Kebenaran Butylparaben Endocrine disrupting properties Endocrine disrupting properties
Icons in SDS
Company Information
syarikat
Pfizer Inc
e-mel
pfizer-MSDS@pfizer.com
